ERG2 and ERG24 Are Required for Normal Vacuolar Physiology as Well as Candida albicans Pathogenicity in a Murine Model of Disseminated but Not Vaginal Candidiasis
Open accessThe DOI matches its Crossref record; 65 of the 65 references it cites were found in a registry or an index.
Abstract
Several important classes of antifungal agents, including the azoles, act by blocking ergosterol biosynthesis. It was recently reported that the azoles cause massive disruption of the fungal vacuole in the prevalent human pathogen Candida albicans . This is significant because normal vacuolar function is required to support C. albicans pathogenicity. This study examined the impact of the morpholine antifungals, which inhibit later steps of ergosterol biosynthesis, on C. albicans vacuolar integrity. It was found that overexpression of either the ERG2 or ERG24 gene, encoding C-8 sterol isomerase or C-14 sterol reductase, respectively, suppressed C. albicans sensitivity to the morpholines. In addition, both erg2Δ/Δ and erg24Δ/Δ mutants were hypersensitive to the morpholines. These data are consistent with the antifungal activity of the morpholines depending upon the simultaneous inhibition of both Erg2p and Erg24p. The vacuoles within both erg2Δ/Δ and erg24Δ/Δ C. albicans strains exhibited an aberrant morphology and accumulated large quantities of the weak base quinacrine, indicating enhanced vacuolar acidification compared with that of control strains. Both erg mutants exhibited significant defects in polarized hyphal growth and were avirulent in a mouse model of disseminated candidiasis. Surprisingly, in a mouse model of vaginal candidiasis, both mutants colonized mice at high levels and induced a pathogenic response similar to that with the controls. Thus, while targeting Erg2p or Erg24p alone could provide a potentially efficacious therapy for disseminated candidiasis, it may not be an effective strategy to treat vaginal infections. The potential value of drugs targeting these enzymes as adjunctive therapies is discussed.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The cited source doesn’t support the claim as written.
In the citing paper
“Cells with a depletion of ERG2 or ERG24 , or treated with azoles or morpholines, reduce the degree of vacuolar acidi fi cation and exhibit an abnormal morphology of the vacuole.”
From The synthesis, regulation, and functions of sterols in Candida albicans: Well-known but still lots to learn (2016) · cites this paper as [78]
Checked by a reasoning model — may be wrong.
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Meanwhile, erg2 D / erg2 D and erg24 D /erg24 D mutant strains have similar phenotypes to vacuolar de fi cient mutants in being hypersensitive to elevated temperature and to high ionic or osmotic stress.”
From The synthesis, regulation, and functions of sterols in Candida albicans: Well-known but still lots to learn (2016) · cites this paper as [78]
Experimental — accuracy not yet measured
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
(1996) · Institutional Research Information System University of Turin (University of Turin) · doi:10.1111/j · Cited by 5,486
Improved method for high efficiency transformation of intact yeast cells
Gietz, D., Jean, A. S., Woods, R. A., & Schiestl, R. H. (1992) · Nucleic Acids Research · doi:10.1093/nar/20.6.1425 · Cited by 3,261
Nonfilamentous C. albicans Mutants Are Avirulent
Lo, H.-J., Köhler, J. R., DiDomenico, B., Loebenberg, D., Cacciapuoti, A., & Fink, G. R. (1997) · Cell · doi:10.1016/s0092-8674(00)80358-x · Cited by 1,809
Methods in yeast genetics : a Cold Spring Harbor Laboratory course manual
Amberg, D. C., Burke, D. J., & Strathern, J. N. (2005) · Cited by 1,803
Isogenic strain construction and gene mapping in Candida albicans.
Fonzi, W. A., & Irwin, M. Y. (1993) · Genetics · doi:10.1093/genetics/134.3.717 · Cited by 1,687
Engineered Luciferase Reporter from a Deep Sea Shrimp Utilizing a Novel Imidazopyrazinone Substrate
Hall, M. P., Unch, J., Binkowski, B. F., Valley, M. P., Butler, B. L., Wood, M. G., Otto, P., Zimmerman, K., Vidugiris, G., Machleidt, T., et al. (2012) · ACS Chemical Biology · doi:10.1021/cb3002478 · Cited by 1,598 · cited 2×
“albicans codon-adapted version of the Nano luciferase (Nluc) (20) coding sequence was produced with permission from Promega Corporation and synthesized by IDT DNA Technologies (see Table S2 in the supplemental material).”
BackgroundMethodA new vital stain for visualizing vacuolar membrane dynamics and endocytosis in yeast.
Vida, T. A., & Emr, S. D. (1995) · The Journal of cell biology · doi:10.1083/jcb.128.5.779 · Cited by 1,360 · cited 2×
“to label the vacuolar membrane, as previously described (30).”
BackgroundMethodGillum, A. M., Tsay, E. Y. H., & Kirsch, D. R. (1984) · Molecular and General Genetics MGG · doi:10.1007/bf00328721 · Cited by 1,251 · cited 1×
“SC5314 has been described previously (22), and”
Antifungal agents: mechanisms of action
Odds, F. C., Brown, A. J. P., & Gow, N. A. R. (2003) · Trends in Microbiology · doi:10.1016/s0966-842x(03)00117-3 · Cited by 1,202 · cited 2×
“Avariety of antifungal therapies act by blocking the biosynthesis of the membrane lipid ergosterol (1).”
BackgroundStillman, B. (1995) · Molecular Medicine · doi:10.1007/bf03401885 · Cited by 1,025
Cited by
Recent Advances in Ergosterol Biosynthesis and Regulation Mechanisms in Saccharomyces cerevisiae
Hu, Z., He, B., Ma, L., Sun, Y., Niu, Y., & Zeng, B. (2017) · Indian Journal of Microbiology · doi:10.1007/s12088-017-0657-1 · Cited by 225
The vaginal mycobiome: A contemporary perspective on fungi in women's health and diseases
Bradford, L. L., & Ravel, J. (2017) · Virulence · doi:10.1080/21505594.2016.1237332 · Cited by 191
Lv, Q.-Z., Yan, L., & Jiang, Y.-Y. (2016) · Virulence · doi:10.1080/21505594.2016.1188236 · Cited by 133
Ergosterol Biosynthesis and Regulation Impact the Antifungal Resistance and Virulence of Candida spp
Eliaš, D., Tóth Hervay, N., & Gbelská, Y. (2024) · Stresses · doi:10.3390/stresses4040041 · Cited by 63
“Based on the viability of deletion mutants in the genes CaERG2 (C-8 sterol isomerase) [47], CaERG6 (C-24 sterol methyltransferase) [30] or CaERG3 (C-5 sterol desat-urase) [31] in C. albicans and CgERG3 [29] and CgERG6 [33] in C. glabrata , these genes are considered non-essential, similar to S.…”
InfluentialErg6 affects membrane composition and virulence of the human fungal pathogen Cryptococcus neoformans
de Oliveira, F. F. M., Paes, H. C., Peconick, L. D. F., Fonseca, F. L., Marina, C. L., Bocca, A. L., Homem-de-Mello, M., Rodrigues, M. L., Albuquerque, P., Nicola, A. M., et al. (2020) · Fungal Genetics and Biology · doi:10.1016/j.fgb.2020.103368 · Cited by 58
“albicans reported increased susceptibility to different stressors (Luna-Tapia et al., 2015) such as osmotic and oxidative agents and compounds that alter cell wall assembly.”
BackgroundInsights into the role of sterol metabolism in antifungal drug resistance: a mini-review
Tanwar, S., Kalra, S., & Bari, V. K. (2024) · Frontiers in Microbiology · doi:10.3389/fmicb.2024.1409085 · Cited by 47
Zhang, T., Cao, Q., Li, N., Liu, D., & Yuan, Y. (2020) · BMC Genomics · doi:10.1186/s12864-020-6564-6 · Cited by 43
Gutierrez-Perez, C., & Cramer, R. A. (2025) · npj Antimicrobials and Resistance · doi:10.1038/s44259-025-00093-4 · Cited by 44
“Thegenes mediating the last fi ve steps of ergosterol synthesis in S. cerevisiae arenotessential( ERG2,ERG3,ERG4,ERG5,ERG6 ) 50 .”
InfluentialLuna-Tapia, A., Willems, H. M. E., Parker, J. E., Tournu, H., Barker, K. S., Nishimoto, A. T., Rogers, P. D., Kelly, S. L., Peters, B. M., & Palmer, G. E. (2018) · mBio · doi:10.1128/mbio.00225-18 · Cited by 29
“albicans erg2 / and erg24 / mutants (lacking C-8 sterol isomerase and C-14 sterol reductase, respectively) are avirulent in the mouse model of disseminated infection but readily colonize the mouse vagina (26) further supports the notion that mucosal environments may be more permissive of alterations in the ergosterol…”
BackgroundSelf-citationTournu, H., Luna-Tapia, A., Peters, B. M., & Palmer, G. E. (2017) · mSphere · doi:10.1128/msphere.00276-17 · Cited by 27
“albicans carboxypeptidase Y (Cpy1p) prepropeptide (codons 1 to 129) (12, 13) to yield CPP-PHL2.”
BackgroundSelf-citationThe Effect of Honokiol on Ergosterol Biosynthesis and Vacuole Function inCandida albicans
Sun, L., & Liao, K. (2020) · Journal of Microbiology and Biotechnology · doi:10.4014/jmb.2008.08019 · Cited by 27
“There are previously reported data that cells with ERG2 or ERG24 deletion, or exposure to ergosterol biosynthesis inhibitors morpholines or azoles, decrease the degree of vacuolar acidification and show an abnormal morphology of the vacuole [33].”
BackgroundLi, Y., Dai, M., Zhang, Y., & Lü, L. (2021) · Applied Microbiology and Biotechnology · doi:10.1007/s00253-021-11104-5 · Cited by 24
Zhou, X., Hilk, A. L., Solis, N. V., de Sá, N. P., Hogan, B. M., Bierbaum, T. A., Poeta, M. D., Filler, S. G., Burrack, L. S., & Selmecki, A. M. (2024) · PLoS Pathogens · doi:10.1371/journal.ppat.1012389 · Cited by 20
Mandelblat, M., Frenkel, M., Abbey, D., Ben‐Ami, R., Berman, J. G., & Segal, E. (2017) · Mycoses · doi:10.1111/myc.12623 · Cited by 22
“[49], which indicated that ERG2 and ERG24 are required for pathogenicity of C.”
BackgroundHirayama, T., Miyazaki, T., Sumiyoshi, M., Ashizawa, N., Takazono, T., Yamamoto, K., Imamura, Y., Izumikawa, K., Yanagihara, K., Kohno, S., et al. (2020) · Pathogens · doi:10.3390/pathogens10010023 · Cited by 16
Identification of small molecules that disrupt vacuolar function in the pathogen Candida albicans
Tournu, H., Carroll, J. L., Latimer, B., Dragoi, A., Dykes, S. S., Cardelli, J. A., Peters, T. L., EBERLE, K. E., & Palmer, G. E. (2017) · PLoS ONE · doi:10.1371/journal.pone.0171145 · Cited by 18
Self-citationToh‐e, A., Ohkusu, M., Shimizu, K., Yamaguchi, M., Ishiwada, N., Watanabe, A., & Kamei, K. (2017) · Current Genetics · doi:10.1007/s00294-017-0713-8 · Cited by 17
“Since it is well known that vacuolar function is intimately related with ergosterol biosynthesis (Luna-Tapia et al. 2015; Zhang and Rao 2010), we extended our analysis on micafungin-resistance to vacuolar function.”
BackgroundXu, X., Cao, X., Yang, J., Chen, L., Liu, B., Liu, T., & Jin, Q. (2019) · Frontiers in Microbiology · doi:10.3389/fmicb.2019.02613 · Cited by 17
Luna-Tapia, A., Butts, A., & Palmer, G. E. (2019) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.01337-18 · Cited by 14
“Plasmids pKE1 (34), pKE1Nluc (35), pKE4 (16), pKE4CDR1 (16), pAR8 (36), pAR8-ERG11 (36), pKE1:GFP-YPT72 (25), and pDUP3 (37) were described previously.”
Self-citationButts, A., DeJarnette, C. A., Peters, T. L., Parker, J. E., Kerns, M. E., EBERLE, K. E., Kelly, S. L., & Palmer, G. E. (2017) · mSphere · doi:10.1128/msphere.00379-17 · Cited by 14
“albicans expression vectors pKE1 (ACT1pr) (33) and pKE3 (ENO1pr) (34) have been previously described.”
Self-citationEndosomal Trafficking Defects Can Induce Calcium-Dependent Azole Tolerance in Candida albicans
Luna-Tapia, A., Tournu, H., Peters, T. L., & Palmer, G. E. (2016) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.01034-16 · Cited by 12
“We therefore examined plasma membrane integrity following azole treatment using a luciferasebased assay (15) to determine if the vps21 / mutant exhibited signs of membrane damage.”
MethodSelf-citationFluorescent toys ‘n’ tools lighting the way in fungal research
Genechten, W. V., Dijck, P. V., & Demuyser, L. (2021) · FEMS Microbiology Reviews · doi:10.1093/femsre/fuab013 · Cited by 16
“It uses the commercial Nano-Glo containing furimazine as a substrate and is ATP-independent (Luna-Tapia et al. 2015; Masser et al. 2016).”
MethodJiang, L., Zhang, L., Rui, C., Liu, X., Mao, Z., Yan, L., Luan, T., Wang, X., Wu, Y., Li, P., et al. (2019) · Scientific Reports · doi:10.1038/s41598-019-50902-w · Cited by 10
Functional study of two ER localized sterol C-14 reductases in Aspergillus oryzae
Shang, Y., Jin, Q., Li, G., Yan, H., Yu, M., & Hu, Z. (2024) · 3 Biotech · doi:10.1007/s13205-024-03988-7 · Cited by 6
“In C. albicans , Erg24 is critical for fungal virulence and drug resistance, and Erg24 null mutant cells have multilayered or densely clustered vacuolar defect structures (Jia et al. 2002; Luna-Tapia et al. 2015).”
Regan, J., DeJarnette, C. A., Luna-Tapia, A., Parker, J. E., Reitler, P., Barnett, S., Tucker, K. M., Kelly, S. L., & Palmer, G. E. (2022) · mBio · doi:10.1128/mbio.00115-22 · Cited by 5
“All mice infected with the wild-type strain succumbed to infection within 6 days and all those infected with the promoter replacement strains within 7 days (Fig.”
Self-citationOttaviano, E., Dei, M., Ancona, S., Triva, F., Casati, S., Sisto, F., & Borghi, E. (2025) · Microbiology Spectrum · doi:10.1128/spectrum.02987-24 · Cited by 4
“Previous research has demonstrated that targeting the Erg2 enzyme could be an effective strategy to reduce C. albicans invasiveness and treat disseminated infections (28).”
Yang, S., & Peng, L. (2023) · Advances in applied microbiology · doi:10.1016/bs.aambs.2023.07.001 · Cited by 8
Eliaš, D., Hervay, N. T., Černáková, L., & Gbelská, Y. (2024) · Journal of Fungi · doi:10.3390/jof10100669 · Cited by 3
Resistance of ERG24 sterol C-14 reductase to heterocyclic amine antifungals
Arnold, C. J., Chartrain, L., Lawson, D. M., & Brown, J. K. M. (2025) · npj Antimicrobials and Resistance · doi:10.1038/s44259-025-00155-7 · Cited by 1
“Amine antifungals inhibit two enzymes, ERG24 and ERG2, which catalyse reduction or rearrangement of C:C double bonds in sterol synthesis 10,11,40,41 andthusarrestfungalcelldivision 42 (SupplementaryFig.1).”
DeJarnette, C. A. (2020) · doi:10.21007/etd.cghs.2020.0518 · Cited by 2
Nausa, J. G. (2015) · Nova eBooks
Micafungin exposure drives multidrug resistance in Clavispora lusitaniaePreprint
Wash, E., Scott, N. E., Metzner, K., Zhou, X., Dasilva, D., de Sá, N. P., Usmani, S. A., Sa, N. F. V. D., Poeta, M. D., & Selmecki, A. M. (2026) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.64898/2026.06.29.735437
Zhou, R., Pandey, A. M., Singh, D., Jaiswal, A., Rohlwing, N. J., Le, A., Koo, J., Ong, Z. Y., Herdrich, J., Chen, Y., et al. (2026) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.64898/2026.08.10.744041
Metadata
- Authors
- Luna-Tapia, A., Peters, B. M., Eberle, K. E., Kerns, M. E., Foster, T. P., Marrero, L., Noverr, M. C., Fidel, P. L., & Palmer, G. E.
- Affiliations
- University of Tennessee Health Science Center (US)
- Louisiana State University (US)
- Louisiana State University Health Sciences Center New Orleans (US)
- Venue
- Eukaryotic Cell
- Publisher
- American Society for Microbiology
- Published
- 2015-10
- Volume
- 14
- Issue
- 10
- Pages
- 1006-1016
- ISSN
- 1535-9778 (ISSN-L)
- 1535-9786
- PMC
- PMC4588627
- OpenAlex
- W2257489507
- Cited by
- 35
- References
- 64
- Citations by year
- 2026: 2 · 2025: 3 · 2024: 6 · 2023: 1 · 2022: 1 · 2021: 2 · 2020: 6 · 2019: 2 · 2018: 2 · 2017: 6 · 2016: 3 · 2015: 1
- FWCI
- 3.11
- Type
- journal article
- Language
- en
- Open access
- diamond
- doi.org
- Licence
- journals.asm.org/non-commercial-tdm-license (tdm)
- Locations
- Eukaryotic Cell (publishedVersion)
- Europe PMC (PubMed Central) (publishedVersion)
- PubMed Central (publishedVersion)
- PubMed (publishedVersion)
- Repositorio Institucional Universidad de Sucre (submittedVersion, cc-by-nc-nd)
- Funders
- Carnegie Mellon University
- Georgetown University
- National Institutes of Health
- National Institute of Allergy and Infectious Diseases (R21AI097664, R01AI099080)
- Topics
- Health Sciences › Medicine › Infectious Diseases › Antifungal resistance and susceptibility
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Fungal and yeast genetics research
- Health Sciences › Medicine › Infectious Diseases › Fungal Infections and Studies
- Keywords
- Candida albicans, ERG2, ergosterol biosynthesis, vacuolar acidification, systemic candidiasis, vaginal candidiasis, fungal pathogenicity, antifungal resistance
- MeSH terms
- Animals, Antifungal Agents, Candida albicans, Candidiasis, Vulvovaginal, Ergosterol, Female, Fungal Proteins, Mice, Inbred BALB C, Mice, Inbred C57BL, Microbial Sensitivity Tests, Morpholines, Oxidoreductases, Steroid Isomerases, Vacuoles, Drug Resistance, Fungal, Hyphae, Cathepsin A, Mice, Candidiasis, Invasive
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.